115 related articles for article (PubMed ID: 11478395)
21. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
22. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity.
Bendelac A; Medzhitov R
J Exp Med; 2002 Mar; 195(5):F19-23. PubMed ID: 11877490
[No Abstract] [Full Text] [Related]
23. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
Chisholm D; Libet L; Hayashi T; Horner AA
J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
[TBL] [Abstract][Full Text] [Related]
24. The potential of CpG oligodeoxynucleotides as mucosal adjuvants.
McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
Crit Rev Immunol; 2001; 21(1-3):103-20. PubMed ID: 11642598
[TBL] [Abstract][Full Text] [Related]
25. TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines.
Daubenberger CA
Curr Opin Mol Ther; 2007 Feb; 9(1):45-52. PubMed ID: 17330401
[TBL] [Abstract][Full Text] [Related]
26. Protein/peptide and DNA vaccine delivery by targeting C-type lectin receptors.
Tang CK; Sheng KC; Apostolopoulos V; Pietersz GA
Expert Rev Vaccines; 2008 Sep; 7(7):1005-18. PubMed ID: 18767950
[TBL] [Abstract][Full Text] [Related]
27. Structural requirements for uptake and recognition of CpG oligonucleotides.
Heeg K; Dalpke A; Peter M; Zimmermann S
Int J Med Microbiol; 2008 Jan; 298(1-2):33-8. PubMed ID: 17706458
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
Ozato K; Tsujimura H; Tamura T
Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
[TBL] [Abstract][Full Text] [Related]
29. CpG motifs for optimization of DNA vaccines.
Davis HL
Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816
[TBL] [Abstract][Full Text] [Related]
30. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
31. From tolerance to autoimmunity: is there a risk in early life vaccination?
Goriely S; Goldman M
J Comp Pathol; 2007 Jul; 137 Suppl 1():S57-61. PubMed ID: 17548092
[TBL] [Abstract][Full Text] [Related]
32. The science of adjuvants.
Kwissa M; Kasturi SP; Pulendran B
Expert Rev Vaccines; 2007 Oct; 6(5):673-84. PubMed ID: 17931149
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the development of immunostimulatory oligonucleotides.
Uhlmann E; Vollmer J
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):204-17. PubMed ID: 12669456
[TBL] [Abstract][Full Text] [Related]
34. Beta-glucans as conductors of immune symphonies.
Dalmo RA; Bøgwald J
Fish Shellfish Immunol; 2008 Oct; 25(4):384-96. PubMed ID: 18606550
[TBL] [Abstract][Full Text] [Related]
35. Vaccine protocols for enhanced immunogenicity of exogenous antigens.
Heit A; Busch DH; Wagner H; Schmitz F
Int J Med Microbiol; 2008 Jan; 298(1-2):27-32. PubMed ID: 17888726
[TBL] [Abstract][Full Text] [Related]
36. Will adjuvants be needed for vaccines of the future?
Bomford R
Dev Biol Stand; 1998; 92():13-7. PubMed ID: 9554255
[TBL] [Abstract][Full Text] [Related]
37. Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination.
Wang L; Smith D; Bot S; Dellamary L; Bloom A; Bot A
J Clin Invest; 2002 Oct; 110(8):1175-84. PubMed ID: 12393853
[TBL] [Abstract][Full Text] [Related]
38. Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands.
Xu Z; Moyle PM
Bioconjug Chem; 2018 Mar; 29(3):572-586. PubMed ID: 28891637
[TBL] [Abstract][Full Text] [Related]
39. Natural products and the search for novel vaccine adjuvants.
Rey-Ladino J; Ross AG; Cripps AW; McManus DP; Quinn R
Vaccine; 2011 Sep; 29(38):6464-71. PubMed ID: 21787827
[TBL] [Abstract][Full Text] [Related]
40. Vaccine adjuvants: putting innate immunity to work.
Coffman RL; Sher A; Seder RA
Immunity; 2010 Oct; 33(4):492-503. PubMed ID: 21029960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
